Skip to main content

Breast Cancer Research and Treatment

Ausgabe 3/2023

Inhalt (20 Artikel)

Review

Reporting of older subgroups in registration breast cancer trials 2012–2021

Colm Mac Eochagain, Nicolò Matteo Luca Battisti

Preclinical study

Intraoperative assessment of axillary sentinel lymph nodes by telepathology

Gulisa Turashvili, Sandra Gjorgova Gjeorgjievski, Qun Wang, Abdulwahab Ewaz, Di Ai, Xiaoxian Li, Sunil S. Badve

Clinical trial

Do bilateral procedures further increase the complications for autologous breast reconstruction in obese patients?

Bulent Sacak, Ahmet Hamdi Sakarya, Adem Atakan Haytaoglu, Zeynep Akdeniz Dogan, Mustafa Umit Ugurlu

Open Access Clinical trial

Absence of post-treatment changes in sentinel lymph nodes does not translate into increased regional recurrence rate in initially node-positive breast cancer patients

Nina Pislar, Gorana Gasljevic, Ivica Ratosa, Anja Kovac, Janez Zgajnar, Andraz Perhavec

Clinical trial

Inter-reader agreement of breast magnetic resonance imaging and contrast-enhanced mammography in breast cancer diagnosis: a multi-reader retrospective study

Filippo Pesapane, Luca Nicosia, Priyan Tantrige, Simone Schiaffino, Alessandro Liguori, Marta Montesano, Anna Bozzini, Anna Rotili, Michaela Cellina, Marcello Orsi, Silvia Penco, Maria Pizzamiglio, Gianpaolo Carrafiello, Enrico Cassano

Open Access Clinical trial

Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy

Rebecca Pedersini, Marta Laganà, Sara Bosio, Barbara Zanini, Deborah Cosentini, Pierluigi di Mauro, Andrea Alberti, Greta Schivardi, Lara Laini, Giuseppe Ippolito, Vito Amoroso, Lucia Vassalli, Edda Lucia Simoncini, Alfredo Berruti, Francesco Donato

Open Access Clinical trial

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer

Shinsuke Sasada, Naoto Kondo, Hiroya Hashimoto, Yuko Takahashi, Kaori Terata, Kumiko Kida, Yasuaki Sagara, Takayuki Ueno, Keisei Anan, Akihiko Suto, Chizuko Kanbayashi, Mina Takahashi, Rikiya Nakamura, Toshiyuki Ishiba, Michiko Tsuneizumi, Seiichiro Nishimura, Yoichi Naito, Fumikata Hara, Tadahiko Shien, Hiroji Iwata

Open Access Clinical trial

A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer

Masahiro Takada, Shigeru Imoto, Takanori Ishida, Yoshinori Ito, Hiroji Iwata, Norikazu Masuda, Hirofumi Mukai, Shigehira Saji, Takafumi Ikeda, Hironori Haga, Toshiaki Saeki, Kenjiro Aogi, Tomoharu Sugie, Takayuki Ueno, Shinji Ohno, Hiroshi Ishiguro, Chizuko Kanbayashi, Takeshi Miyamoto, Yasuhiro Hagiwara, Masakazu Toi

Open Access Clinical trial

Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study

Steffi Hartmann, Maggie Banys-Paluchowski, Elmar Stickeler, Jana de Boniface, Oreste Davide Gentilini, Michalis Kontos, Stephan Seitz, Gabriele Kaltenecker, Fredrik Wärnberg, Linda Holmstrand Zetterlund, Hans-Christian Kolberg, Sarah Fröhlich, Thorsten Kühn

Epidemiology

Digital mammography and digital breast tomosynthesis for detecting invasive lobular and ductal carcinoma

Tracy Onega, Linn Abraham, Diana L. Miglioretti, Christoph I. Lee, Louise M. Henderson, Karla Kerlikowske, Anna N. A. Tosteson, Donald Weaver, Brian L. Sprague, Erin J. Aiello Bowles, Roberta M. di Florio-Alexander

Epidemiology

Delayed breast cancer presentation, diagnosis, and treatment in Kenya

Ojuka Daniel, Adiba Ashrafi, Musibi Alice Muthoni, Njiraini Njoki, Hungu Eric, Omondi Marilynn, Aseta Bonareri Faith, Wambui Githambo Beth, Mburu Nyakio, Valerie Odero-Marah, Camille Ragin, Adana A. M. Llanos

Epidemiology

Patients’ experiences undergoing breast evaluation in Rwanda’s Women’s Cancer Early Detection Program

Lydia E. Pace, Amanda M. Fata, Vincent K. Cubaka, Theophile Nsemgiyumva, Jean de Dieu Uwihaye, Catherine Stauber, Jean-Marie Vianney Dusengimana, Kayleigh Bhangdia, Lawrence N. Shulman, Anna Revette, Marc Hagenimana, Francois Uwinkindi, Enock Rwamuza

Epidemiology

Long-term locoregional recurrence in patients treated for breast cancer

Beatriz Costeira, Francisca Brito da Silva, Filipa Fonseca, Rodrigo Oom, Cristina Costa, João Vargas Moniz, Nuno Abecasis, Catarina Rodrigues Santos

Open Access Original Laboratory Investigation

Genetic analysis of low-grade adenosquamous carcinoma of the breast progressing to high-grade metaplastic carcinoma

Kae Kawachi, Xiaoyan Tang, Rika Kasajima, Takashi Yamanaka, Eigo Shimizu, Kotoe Katayama, Rui Yamaguchi, Kazuaki Yokoyama, Kiyoshi Yamaguchi, Yoichi Furukawa, Satoru Miyano, Seiya Imoto, Emi Yoshioka, Kota Washimi, Yoichiro Okubo, Shinya Sato, Tomoyuki Yokose, Yohei Miyagi

Open Access Original Laboratory Investigation

Baseline interleukin-6 is a prognostic factor for patients with metastatic breast cancer treated with eribulin

Ayako Bun, Masayuki Nagahashi, Mamiko Kuroiwa, Miki Komatsu, Yasuo Miyoshi

Open Access Original Laboratory Investigation

The effect of aquatic and land exercise on the mental well-being of women following breast cancer surgery-comparative study

Ewelina Czenczek-Lewandowska, Ewa Szeliga, Justyna Leszczak

Original Laboratory Investigation

Monopolar spindle 1 contributes to tamoxifen resistance in breast cancer through phosphorylation of estrogen receptor α

Xuemiao Zhang, Linfei Huang, Jing Sun, Jialong Liu, Yulong Zong, Luming Wan, Xiaopan Yang, Xue Yan, Yanhong Zhang, Ruzhou Zhao, Jing Liu, Hui Zhong, Congwen Wei, Xiaoli Yang, Yanhong Tai, Yue Han, Yanhai Wang

Open Access Original Laboratory Investigation

Performance of a RAD51-based functional HRD test on paraffin-embedded breast cancer tissue

Lise M. van Wijk, Sylvia Vermeulen, Natalja T. ter Haar, Claire J. H. Kramer, Diantha Terlouw, Harry Vrieling, Danielle Cohen, Maaike P. G. Vreeswijk

Letter to the Editor

Immediate breast reconstruction and COVID-19 pandemic: the day after

Francisco Pimentel Cavalcante, Felipe Pereira Zerwes, Eduardo Camargo Millen

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.